Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2022-03-22 Annual Report
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
111年03月法人說明會簡報 — 179520220317M001.pdf
Annual Report Classification · 95% confidence The document is titled '2021 年度營運成果報告' which translates to '2021 Annual Operating Results Report'. It contains detailed financial performance data for the full year 2021, including revenue, profit, EPS, and segment analysis. The document includes comprehensive financial figures, operational highlights, market and product information, and strategic outlook. The length is over 11,000 characters, indicating a substantive report rather than a brief announcement. There is no indication that this is merely an announcement of a report or a certification. The content aligns with a full annual report covering company activity and financial performance for the fiscal year 2021. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2022-03-22 Chinese
111年03月法人說明會簡報 — 179520220322E001.pdf
Investor Presentation Classification · 95% confidence The document is titled 'FY2021 RESULTS Investor Presentation' and dated March 2022. It contains detailed business highlights, financial results, strategic deliverables, market leadership data, regulatory registration updates, R&D pipeline execution, product acquisitions, and market expansion plans. The content is structured as a presentation with agenda points, charts, and forward-looking statements typical of investor presentations. There is no indication that this is a full annual report or a regulatory filing; rather, it is a detailed presentation aimed at investors summarizing the fiscal year results and future strategy. Therefore, the document fits the category of an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2022-03-22 Chinese
111年03月法人說明會簡報 — 179520220322M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation of the company's 2021 annual operational results and 2022 business priorities. It includes comprehensive financial data such as revenue, gross profit, operating expenses, net income, and EPS for the fiscal year 2021. It also discusses product portfolio, market expansion, R&D progress, and strategic acquisitions. The document is lengthy (over 13,000 characters) and contains substantive financial data and analysis, not just an announcement or summary. It is not a transcript, audit report, or regulatory filing. The content aligns with a comprehensive annual report or a detailed investor presentation. However, the format and style, including forward-looking statements, detailed financials, and strategic outlook, strongly indicate it is an Investor Presentation rather than the official Annual Report (10-K). Therefore, the best classification is Investor Presentation (IP).
2022-03-22 Chinese
111年03月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing of scheduled investor presentations (法人說明會) with dates, times, locations, and links to presentation materials. It includes references to financial and operational status explanations to investors, typical of investor presentations. The document is short (1266 characters) and does not contain actual financial statements or detailed financial analysis. It is not an announcement of a report publication but a schedule and summary of investor presentations. Therefore, the document best fits the category of Investor Presentation (IP).
2022-03-22 Chinese
111年03月法人說明會簡報 — 179520220317E001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation of FY2021 financial results and business highlights for the company 1795.TT, dated March 2022. It includes comprehensive financial data such as sales, profit margins, EPS, capital structure, R&D pipeline, regulatory updates, market expansion, and acquisitions. The content is structured as a presentation with agenda, charts, and detailed explanations of financial performance and strategic initiatives. There is no indication that this is a full annual report filing (10-K) or an audit report. The format and content align with an Investor Presentation (IP), which typically provides detailed financials, strategy, and market position to investors. The length (over 14,000 characters) and depth of financial and business information support this classification. Therefore, the document is best classified as an Investor Presentation (IP).
2022-03-17 Chinese
111年03月法人說明會簡報 — 179520220317M001.pdf
Annual Report Classification · 95% confidence The document is titled '2021 年度營運成果報告' which translates to '2021 Annual Operating Results Report'. It contains detailed financial performance data for the full year 2021, including revenue, profit, EPS, and segment analysis. The document includes comprehensive financial figures, operational highlights, market and product information, and strategic outlook. The length is over 11,000 characters, indicating a substantive report rather than a brief announcement. The content is consistent with a full annual report covering company activity and financial performance for the fiscal year 2021. There is no indication that this is merely an announcement or a presentation, nor is it a transcript or a regulatory filing of a different nature. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2022-03-17 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.